News
Although obinutuzumab has not yet received FDA approval in lupus nephritis, findings from a recent survey conducted by ...
From trade associations to medtech innovators and biotech start-ups, here’s a comprehensive look at the latest boardroom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results